<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation-group" /><meta name="keywords" content="" /><title>With atenolol: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="2698.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="2698.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=2698.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="1002.htm">2 Cardiovascular system</a> &gt; <a href="2614.htm">2.6 Nitrates, calcium-channel blockers, and other antianginal drugs</a> &gt; <a href="2616.htm">2.6.2 Calcium-channel blockers</a> &gt; <a href="2691.htm">NIFEDIPINE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="2687.htm" title="Previous: NICARDIPINE HYDROCHLORIDE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="2699.htm" title="Next: NIMODIPINE">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a384028.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Nifedipine</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Cardiovascular Drugs 24:00 &gt; Calcium-Channel Blocking Agents 24:28 &gt; Dihydropyridines 24:28.08</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/9263-k.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Nifedipine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: N &gt; Interactions of Nifedipine</p></div></li></ul><ul><li><h3>British National Formulary (20)</h3></li><li><a href="29458.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Miscellaneous conditions</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Guidance on prescribing &gt; Prescribing in palliative care</p></div></li><li><a href="2477.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Beta-Adalat®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.4 Beta-adrenoceptor blocking drugs &gt; ATENOLOL &gt; With calcium-channel blocker</p></div></li><li><a href="2478.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tenif®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.4 Beta-adrenoceptor blocking drugs &gt; ATENOLOL &gt; With calcium-channel blocker</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22nifedipine%22%22nifedipine%22%22nifedipine%22%22raynaud%E2%80%99s+syndrome%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (20)</a></li></ul><ul><li><h3>BNF for Children (20)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/129173.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">2.5.1.2 Pulmonary hypertension</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension &gt; 2.5.1 Vasodilator
antihypertensive drugs and pulmonary hypertension</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2616.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">2.6.2 Calcium-channel blockers</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.6 Nitrates,
calcium-channel blockers, and other antianginal drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2691.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">NIFEDIPINE</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.6 Nitrates,
calcium-channel blockers, and other antianginal drugs &gt; 2.6.2 Calcium-channel blockers</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22nifedipine%22%22nifedipine%22%22nifedipine%22%22raynaud%E2%80%99s+syndrome%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (20)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1170.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Nifedipine</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; N</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0013s0154.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Nifedipine</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; N</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/850-a11-5-z.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vasospastic arterial disorders</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Other Vascular Disorders</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/9263-k.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Nifedipine</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/06528.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Nifedipine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; N &gt; NI</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E10E3E0R0D31.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Nifedipine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; N</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c271.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Nifedipine</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; N</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_2691">NIFEDIPINE</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i475.htm" title="Go to appendix 1">Nifedipine</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">prophylaxis of angina; hypertension; Raynaud’s phenomenon; premature
labour (<a title="BNF:sub-section: Myometrial relaxants" href="4512.htm#_4512">section 7.1.3</a>)</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">see <a title="target-block: Nifedipine notes" href="2616.htm#_2616.1">notes above</a>; also withdraw if ischaemic pain
occurs or existing pain worsens shortly after initiating treatment; poor cardiac reserve; heart failure or significantly impaired left ventricular function
(heart failure deterioration observed); severe hypotension; elderly; diabetes mellitus; acute
porphyria (but see <a title=" Acute porphyrias" href="5181.htm#_5181">section 9.8.2</a>); <b>interactions:</b> Appendix 1
(calcium-channel blockers)</p></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">cardiogenic shock; advanced aortic stenosis; within
1 month of myocardial infarction; unstable or acute attacks of angina</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">dose reduction may be required in severe liver disease</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">may inhibit labour; manufacturer advises avoid before
week 20; risk to fetus should be balanced against risk of uncontrolled
maternal hypertension; use only if other treatment options are not
indicated or have failed</p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">amount too small to be harmful but manufacturers
advise avoid</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">gastro-intestinal disturbance; hypotension, oedema,
vasodilatation, palpitation; headache, dizziness, lethargy, asthenia; <i>less commonly</i> tachycardia, syncope, chills, nasal congestion,
dyspnoea, anxiety, sleep disturbance, vertigo, migraine, paraesthesia,
tremor, polyuria, dysuria, nocturia, erectile dysfunction, epistaxis,
myalgia, joint swelling, visual disturbance, sweating, hypersensitivity
reactions (including angioedema, jaundice, pruritus, urticaria, and
rash); <i>rarely</i> anorexia, gum hyperplasia, mood disturbances,
hyperglycaemia, male infertility, purpura, and photosensitivity reactions;
also reported dysphagia, intestinal obstruction, intestinal ulcer,
bezoar formation (with some modified-release preparations), gynaecomastia,
agranulocytosis, and anaphylaxis; <b>overdosage</b>, see <a title="BNF:monograph-family: Calcium-channel blockers" href="128193.htm#_128193">Emergency Treatment of Poisoning</a></p></div><div class="cAF"><h2>Dose</h2> <p class="cR">See preparations below</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="106042.htm#_106042" title="Nifedipine">Nifedipine</a></li><li><a href="2692.htm#_2692" title="Adalat®">Adalat®</a></li><li id="_2693__2693"><a href="2693.htm#_2693" title="Modified release">Modified release</a><ul style="display: none"><li><a href="2694.htm#_2694" title="Adalat® LA">Adalat® LA</a></li><li><a href="2695.htm#_2695" title="Adalat® Retard">Adalat® Retard</a></li><li><a href="38319.htm#_38319" title="Adipine® MR">Adipine® MR</a></li><li><a href="129303.htm#_129303" title="Adipine® XL">Adipine® XL</a></li><li><a href="2696.htm#_2696" title="Coracten SR®">Coracten SR®</a></li><li><a href="77379.htm#_77379" title="Coracten XL®">Coracten XL®</a></li><li><a href="74007.htm#_74007" title="Fortipine LA 40®">Fortipine LA 40®</a></li><li><a href="69325.htm#_69325" title="Nifedipress® MR">Nifedipress® MR</a></li><li><a href="56446.htm#_56446" title="Tensipine MR®">Tensipine MR®</a></li><li><a href="200868.htm#_200868" title="Valni XL®">Valni XL®</a></li></ul></li><li class="jN" id="_2698" style="margin: 0 0 0 20px;"><h1 class="title">With atenolol</h1><p><a title=" Beta-adrenoceptor blocking drugs" href="2455.htm#_2455">Section 2.4</a></p></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="2687.htm">Previous: NICARDIPINE HYDROCHLORIDE</a> | <a class="top" href="2698.htm#">Top</a> | <a accesskey="]" href="2699.htm">Next: NIMODIPINE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>